Mural Oncology shares are trading higher after Raymond James initiated coverage on the stock with a Strong Buy and announced an $18 price target.
Portfolio Pulse from Benzinga Newsdesk
Mural Oncology shares surged after Raymond James initiated coverage with a Strong Buy rating and set an $18 price target.
October 04, 2024 | 12:22 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Raymond James initiated coverage on Mural Oncology with a Strong Buy rating and an $18 price target, leading to a rise in the stock price.
The initiation of coverage by a reputable firm like Raymond James with a Strong Buy rating and a specific price target is a positive signal to investors, likely leading to increased buying interest and a rise in the stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100